These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 10845432
21. TNFalpha, interleukin-10 and interleukin-18 expression in cells of the bronchoalveolar lavage in patients with pulmonary complications following bone marrow or peripheral stem cell transplantation: a preliminary study. Hauber HP, Mikkilä A, Erich JM, Kröger N, Meyer A, Schoder V, Zander AR, Pforte A. Bone Marrow Transplant; 2002 Oct; 30(8):485-90. PubMed ID: 12379886 [Abstract] [Full Text] [Related]
22. [KL-6 in patients with interstitial pneumonitis]. Hamada H, Sakatani M, Ueda E. Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):771-7. PubMed ID: 8810758 [Abstract] [Full Text] [Related]
24. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients. Küpeli E, Karnak D, Beder S, Kayacan O, Tutkak H. Respiration; 2008 Jul; 75(1):73-8. PubMed ID: 17975298 [Abstract] [Full Text] [Related]
25. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis. Pellegrini P, Totaro R, Contasta I, Berghella AM, Carolei A, Adorno D. Neuroimmunomodulation; 2005 Jul; 12(4):220-34. PubMed ID: 15990453 [Abstract] [Full Text] [Related]
29. Elevated levels of MCP-1, MIP-alpha and MIP-1 beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Emad A, Emad V. Toxicology; 2007 Oct 30; 240(1-2):60-9. PubMed ID: 17720292 [Abstract] [Full Text] [Related]
30. The clinical significance of interleukin 18 assessment in sarcoidosis patients. Kieszko R, Krawczyk P, Jankowska O, Chocholska S, Król A, Milanowski J. Respir Med; 2007 Apr 30; 101(4):722-8. PubMed ID: 17015003 [Abstract] [Full Text] [Related]
32. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis. Meloni F, Caporali R, Marone Bianco A, Paschetto E, Morosini M, Fietta AM, Patrizio V, Bobbio-Pallavicini F, Pozzi E, Montecucco C. Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun 30; 21(2):111-8. PubMed ID: 15281432 [Abstract] [Full Text] [Related]
35. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of the activity of interstitial pulmonary diseases. III: Phospholipids to protein concentration ratio]. Zielonka TM, Wałajtys-Rode E, Jasińska R, Chazan R, Droszcz W. Przegl Lek; 1999 Jun 30; 56(2):144-7. PubMed ID: 10375948 [Abstract] [Full Text] [Related]
36. Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid. Sobiecka M, Kus J, Demkow U, Filewska M, Jozwik A, Radwan-Rohrenschef P, Chorostowska-Wynimko J. J Physiol Pharmacol; 2008 Dec 30; 59 Suppl 6():645-57. PubMed ID: 19218691 [Abstract] [Full Text] [Related]
37. CD30 supports lung inflammation. Nam SY, Kim YH, Do JS, Choi YH, Seo HJ, Yi HK, Hwang PH, Song CH, Lee HK, Kim JS, Podack ER. Int Immunol; 2008 Feb 30; 20(2):177-84. PubMed ID: 18089617 [Abstract] [Full Text] [Related]
39. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients. Mamessier E, Milhe F, Badier M, Thomas P, Magnan A, Reynaud-Gaubert M. J Heart Lung Transplant; 2006 May 30; 25(5):523-32. PubMed ID: 16678030 [Abstract] [Full Text] [Related]